Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Satellos Bioscience Inc (MSCL.TO)

Satellos Bioscience Inc (MSCL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 314,561
  • Shares Outstanding, K 20,627
  • Annual Sales, $ 0 K
  • Annual Income, $ -19,579 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.52
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 6.80

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.05
  • Number of Estimates 1
  • High Estimate -0.05
  • Low Estimate -0.05
  • Prior Year -0.06
  • Growth Rate Est. (year over year) +16.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.80 +41.48%
on 01/21/26
17.00 -10.12%
on 02/04/26
+4.60 (+43.07%)
since 01/20/26
3-Month
7.56 +102.12%
on 12/23/25
17.00 -10.12%
on 02/04/26
+6.64 (+76.85%)
since 11/20/25
52-Week
6.24 +144.87%
on 06/17/25
17.00 -10.12%
on 02/04/26
+6.04 (+65.37%)
since 02/20/25

Most Recent Stories

More News
Satellos to Host Virtual KOL Event on SAT-3247 in Duchenne Muscular Dystrophy

Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL) (“Satellos” or the “Company”), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle...

MSLE : 11.18 (+0.63%)
MSCL.TO : 15.28 (+0.20%)
Satellos to Participate in Upcoming Investor Conferences

Satellos Bioscience Inc. (Nasdaq: MSLE , TSX: MSCL ) (“Satellos” or the “Company”), a clinical-stage biotechnology company focused on restoring natural muscle...

MSLE : 11.18 (+0.63%)
MSCL.TO : 15.28 (+0.20%)
Stocks in play: Satellos Bioscience Inc.

Today announced that the first participant has been dosed in BASECAMP, a three-month, randomized, double-blind, ...

MSCL.TO : 15.28 (+0.20%)
Satellos Announces First Participant Dosed in Phase 2 Pediatric Study of SAT-3247 for Duchenne Muscular Dystrophy

BASECAMP, a three-month, randomized, double-blind, placebo-controlled study, will evaluate SAT-3247’s safety and tolerability, and effect on muscle force, muscle quality and muscle regeneration

MSCLF : 0.9230 (+1.41%)
MSCL.TO : 15.28 (+0.20%)
Satellos to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit 2026

Satellos Bioscience Inc. (Nasdaq: MSLE , TSX: MSCL ) (“Satellos” or the “Company”), a clinical-stage biotechnology company focused on restoring natural muscle...

MSLE : 11.18 (+0.63%)
MSCL.TO : 15.28 (+0.20%)
Satellos Closes US$57.2 Million Public Offering in Canada and the United States, Including Exercise of Underwriters’ Option to Purchase Additional Shares

Satellos Bioscience Inc . (Nasdaq: MSLE, TSX: MSCL) (“Satellos” or the “Company”), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle...

MSLE : 11.18 (+0.63%)
MSCL.TO : 15.28 (+0.20%)
Satellos Announces Pricing of US$50 Million Public Offering in Canada and the United States

BASE SHELF PROSPECTUS IS ACCESSIBLE, AND PROSPECTUS SUPPLEMENT WILL BE ACCESSIBLE WITHIN TWO BUSINESS DAYS ON SEDAR+

MSLE : 11.18 (+0.63%)
MSCL.TO : 15.28 (+0.20%)
Satellos Announces Launch of Public Offering in Canada and the United States and Filing of Application to List on Nasdaq

BASE SHELF PROSPECTUS IS ACCESSIBLE, AND PROSPECTUS SUPPLEMENT WILL BE ACCESSIBLE WITHIN TWO BUSINESS DAYS ON SEDAR+

MSCLF : 0.9230 (+1.41%)
MSCL.TO : 15.28 (+0.20%)
Stocks in play: Satellos Bioscience Inc.

Announced the appointment of Antoinette Paone as Chief Development Officer and Head of Regulatory Affairs. ...

MSCL.TO : 15.28 (+0.20%)
Satellos Appoints Antoinette Paone as Chief Development Officer and Head of Regulatory Affairs

Experienced industry leader brings extensive expertise in leading breakthrough therapies through clinical development to marketing approval

GBIO : 5.34 (-6.97%)
MSCLF : 0.9230 (+1.41%)
VRTX : 478.03 (+1.87%)
MSCL.TO : 15.28 (+0.20%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Satellos Bioscience Inc is a regenerative medicine company a biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne...

See More

Key Turning Points

3rd Resistance Point 15.67
2nd Resistance Point 15.58
1st Resistance Point 15.42
Last Price 15.28
1st Support Level 15.17
2nd Support Level 15.08
3rd Support Level 14.92

See More

52-Week High 17.00
Last Price 15.28
Fibonacci 61.8% 12.89
Fibonacci 50% 11.62
Fibonacci 38.2% 10.35
52-Week Low 6.24

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar